IN8bio, Inc. (INAB) vs IRIDEX Corporation (IRIX)
A side-by-side comparison of IN8bio, Inc. and IRIDEX Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INAB
IN8bio, Inc.
$1.45HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT
IRIX
IRIDEX Corporation
$0.70HealthcareDelayed quote: Oct 6, 2026, 9:59 AM EDT
Total return — INAB vs IRIX
growth of $100 · dividends reinvested · last 5yINAB -99.5% (-65.7%/yr)IRIX -89.5% (-36.3%/yr)IRIX compounded faster over this window
Log scale — wide-divergence pair
INAB IRIX
INAB vs IRIX: by the numbers
- •INAB is the larger company ($14M vs $12M market cap).
- •Both run net losses; INAB's is the smaller (0.00% vs -6.88% net margin).
Metrics side by side
Valuation
| Metric | INAB | IRIX |
|---|---|---|
| P/S ratio | N/A | 0.23 |
| P/B ratio | 0.76 | N/A |
Profitability
| Metric | INAB | IRIX |
|---|---|---|
| Gross margin | 0.00% | 36.23% |
| Operating margin | 0.00% | -5.39% |
| Net margin | 0.00% | -6.88% |
| ROE | -101.66% | -97.47% |
| ROIC | -91.74% | -19.53% |
Growth (annualized)
| Metric | INAB | IRIX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -0.57% |
| Total return CAGR (5Y) | -62.88% | -38.13% |
Frequently asked
- How have INAB and IRIX total returns compared?
- Over the past 5 years, INAB delivered -62.88% and IRIX delivered -38.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.